Groupama Asset Managment »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2026-03-31 $991k 1.0M 0.99

More positions owned by Groupama Asset Managment

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Micron Technology (MU)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Motorola Solutions Com New (MSI)
Agnico (AEM)
Raytheon Technologies Corp (RTX)
Parker-Hannifin Corporation (PH)
Wal-Mart Stores (WMT)
Thermo Fisher Scientific (TMO)
Xpo Logistics Inc equity (XPO)

View all positions for Groupama Asset Managment

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Context Capital Management
Bnp Paribas Arbitrage, Snc
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management
SSI Investment Management
Ing Investment Management
UBS Group

View all funds holding Arrowhead Pharmaceuticals In Note 1/1